Related Experiment Video
Updated: Aug 22, 2025

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
Research progress on microRNA in gout
Jing Xie1, Cuixia He1,2, Yue Su1,3
1Clinical Trials Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.
Abstract:
Gout is a common form of arthritis caused by the deposition of sodium urate crystals in the joints and tissues around them. MicroRNAs (miRNAs) are noncoding RNAs that have been shown to be involved in regulating the pathogenesis of gout through multiple cellular signaling pathways, which may be potential targets for the treatment of gout. In this review, we systematically discuss the regulatory roles of related miRNAs in gout, which will provide help for the treatment of gout and miRNAs is expected to become a potential biomarker for gout diagnosis.
Insights
MicroRNAs (miRNAs) regulate gout pathogenesis via cellular pathways. This review explores miRNA roles in gout, highlighting their potential as diagnostic biomarkers and therapeutic targets for this common arthritis.
Area of Science:
- Rheumatology
- Molecular Biology
- Genetics
Background:
- Gout is a prevalent inflammatory arthritis characterized by sodium urate crystal deposition in joints.
- MicroRNAs (miRNAs) are key regulators of gene expression implicated in various diseases.
- Emerging evidence suggests miRNAs play a significant role in gout pathogenesis.
Purpose of the Study:
- To systematically review the regulatory functions of miRNAs in gout.
- To identify potential miRNA-based therapeutic targets for gout treatment.
- To evaluate the utility of miRNAs as diagnostic biomarkers for gout.
Main Methods:
- Systematic literature review of studies investigating miRNA involvement in gout.
- Analysis of cellular signaling pathways regulated by miRNAs in gout pathogenesis.
- Compilation of current research on miRNA expression profiles in gout patients.
Main Results:
- miRNAs significantly influence multiple cellular pathways critical to gout development.
- Specific miRNAs have been identified as key players in the inflammatory response to urate crystals.
- Dysregulated miRNA expression is associated with gout, suggesting their role in disease progression.
Conclusions:
- MicroRNAs are crucial regulators in gout pathogenesis and represent promising therapeutic targets.
- miRNAs hold potential as non-invasive biomarkers for early gout diagnosis and monitoring.
- Further research into miRNA mechanisms can advance gout management strategies.
More Related Videos
Related Concept Videos
MicroRNAs
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

